Sector ratings Genmab A/S Nasdaq

Stocks

Market Closed - Nasdaq 01:30:00 04/09/2026 am IST			5-day change	1st Jan Change
34.41 ^USD	+0.57%		+0.91%	+11.72%

03/09	Handelsbanken Adds Xvivo and Vimian as Sector Favorites, Drops Danish Duo	FW
01/09	Deutsche Bank raises price target for Genmab to 2,500 Danish kroner, reiterates buy	FW

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation	Visibility
WUXI APPTEC CO., LTD.	6.9TCr		AAA
ARGENX SE	6.63TCr		A
INSMED INCORPORATED	2.77TCr	-	A	-		-
BIONTECH SE	2.58TCr	-	-	-		-
WUXI BIOLOGICS (CAYMAN) INC.	2.65TCr		AAA
GENMAB A/S	2.04TCr		A
PHARMAESSENTIA CORPORATION	1.76TCr		AA
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	1.51TCr		AA
EXELIXIS, INC.	1.47TCr		BB
MADRIGAL PHARMACEUTICALS, INC.	1.25TCr	-	B	-		-
ARROWHEAD PHARMACEUTICALS, INC.	1.22TCr	-	BB	-		-
SUMMIT THERAPEUTICS INC.	1.37TCr	-	-	-		-
AKESO, INC.	1.07TCr		B			-
CYTOKINETICS, INCORPORATED	1.03TCr	-	AA	-		-
VAXCYTE, INC.	910.24Cr	-	BBB	-		-
REMEGEN CO., LTD.	886.74Cr		-
IMMUNITYBIO, INC.	868.01Cr	-	CCC	-		-
SPYRE THERAPEUTICS, INC.	769.32Cr	-	BB	-	-	-
SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.	743.88Cr	-	BB	-		-	-
Average	2.02TCr		A
Weighted average by Cap.			A